Lifecore Biomedical to Participate at 12th Annual American Biomanufacturing Summit

Lifecore Biomedical (NASDAQ: LFCR) will participate at the 12th Annual American Biomanufacturing Summit on April 14-15, 2026 in San Francisco.

Rhea-AI Summary

Lifecore Biomedical (NASDAQ: LFCR) will participate at the 12th Annual American Biomanufacturing Summit on April 14-15, 2026 in San Francisco. Lifecore will discuss process development and manufacturing services for injectable programs and staff will be available at Booth 41.

Investors and partners may request meetings via cdmo@lifecore.com.

Argus Apr 8 session

+3.16% close to close Open Argus

Details

News Market Reaction – LFCR

On Apr 8, the day this news came out, LFCR closed 3.16% above the previous close.

Data tracked by StockTitan Argus for the Apr 8 session.

Market Context

This announcement focuses on Lifecore’s presence at the 12th Annual American Biomanufacturing Summit...

Analysis

This announcement focuses on Lifecore’s presence at the 12th Annual American Biomanufacturing Summit, where it will discuss injectables process development and manufacturing. It follows recent CDMO agreement wins and financial updates showing $75.5M in transition-period revenue and a targeted 12% revenue CAGR through 2029. Investors may track how such conferences translate into additional late-stage programs, while also monitoring execution against 2026 guidance and the implications of the registered 20,456,637 resale shares and Series A preferred terms.

Key Figures

Conference dates: April 14–15, 2026 Booth number: 41 Current price: $4.11 +5 more

Conference dates

April 14–15, 2026

12th Annual American Biomanufacturing Summit

Booth number

41

Lifecore booth at American Biomanufacturing Summit

Current price

$4.11

Pre-news trading level

52-week high

$8.9799

LFCR 52-week range high

52-week low

$3.625

LFCR 52-week range low

Registered shares

20,456,637 shares

Shares registered for resale under Form S-3 shelf

Series A PIK dividend

7.5% per annum

Dividend rate on Series A Convertible Preferred Stock

Conversion price

≈$6.53 per share

Adjusted conversion price for Series A Convertible Preferred

Historical Context

5 past events · Latest: Mar 26

5 events

1. Mar 26

   Inducement equity grant

   24h Move

   -5.4%

   Inducement RSU award of 18,500 shares to a new employee.

2. Mar 26

   CDMO agreements

   24h Move

   -7.6%

   Two new CDMO manufacturing agreements adding to late-stage pipeline.

3. Mar 23

   Site transfer deal

   24h Move

   +0.8%

   Commercial site transfer for an aesthetic sterile product with revenue potential.

4. Mar 16

   Earnings and update

   24h Move

   -24.4%

   Revenue growth, margin expansion, and 2026 guidance with higher EBITDA.

5. Mar 10

   Conference participation

   24h Move

   -1.3%

   Participation in KeyBanc healthcare forum and investor meetings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

cdmo

1 terms

cdmo technical

"a fully integrated injectables contract development and manufacturing organization (“CDMO”)"

A contract development and manufacturing organization (CDMO) is a company that provides specialized services to help develop and produce pharmaceutical products for other businesses. Think of it as a contract factory that takes a company's recipe and makes the product on their behalf. For investors, CDMOs are important because they support the growth of pharmaceutical companies and can be key partners in bringing new medicines to market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CHASKA, Minn., April 08, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at the 12^th Annual American Biomanufacturing Summit. The conference will take place April 14 - 15, 2026, in San Francisco, CA.

Details regarding Lifecore’s participation are as follows:

• 12^th Annual American Biomanufacturing Summit
  Details: Lifecore team will be present to discuss process development and manufacturing services for injectables programs.
  Booth number: 41
  Conference Dates: April 14 - 15, 2026
  Location: Hyatt Regency San Francisco Airport, San Francisco, CA

If you are interested in meeting with Lifecore during this event, please reach out to us at: cdmo@lifecore.com.

About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.

Contact Information:
Vida Strategic Partners
Stephanie Diaz (Investors)
415-675-7401
sdiaz@vidasp.com\

Jennifer Arcure (Media)
917-603-0681
jarcure@vidasp.com

Lifecore Biomedical
Ryan D. Lake (CFO)
952-368-6244
ryan.lake@lifecore.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Lifecore Biomedical (LFCR) scheduled to attend the American Biomanufacturing Summit in 2026?

Lifecore will attend on April 14-15, 2026. According to the company, the event takes place at the Hyatt Regency San Francisco Airport, and Lifecore team members will be present to discuss injectable process development and manufacturing services.

Where will Lifecore (LFCR) be located at the 12th Annual American Biomanufacturing Summit?

Lifecore will be at Booth 41 during the conference. According to the company, representatives will use the booth to discuss CDMO services for injectables and to schedule meetings with potential partners and clients.

How can investors or partners schedule a meeting with Lifecore Biomedical (LFCR) at the summit?

Interested parties can request meetings by emailing cdmo@lifecore.com. According to the company, this contact will coordinate on-site meeting times at the Hyatt Regency San Francisco Airport during April 14-15, 2026.

What will Lifecore (LFCR) discuss at the 2026 American Biomanufacturing Summit?

Lifecore will discuss process development and manufacturing services for injectable programs. According to the company, the team will highlight CDMO capabilities and engage with attendees on technical and partnership opportunities.

Is Lifecore Biomedical (LFCR) presenting or exhibiting at the April 2026 biomanufacturing event?

Lifecore is exhibiting at the summit and will staff Booth 41. According to the company, the presence is focused on client engagement and showcasing injectable development and manufacturing services rather than a formal speaking session.